News & Perspective

Feb 05, 2013

Feb 05, 2013

NIH launches trio of trials seeking better flu treatments

(CIDRAP News) – Three large, multi-center studies now in the enrollment stage will assess whether such approaches as a combination of antiviral drugs or the use of borrowed antibodies can improve on existing treatments for influenza, the National Institutes of Health (NIH) announced today.

Jan 27, 2012

Jan 27, 2012

Flu season shows signs of life in US, EU

(CIDRAP News) – Flu activity in the United States and Europe showed more signs of picking up last week, with labs in both parts of the world finding higher percentages of positives in tests of respiratory samples, according to new surveillance reports today.

Jan 20, 2012

Apr 22, 2011

Apr 22, 2011

US flu season nears its end; global levels low

(CIDRAP News) – Influenza activity in the United States continued to fade last week, but the lingering signs included reports of four more flu-related deaths in children, the Centers for Disease Control and Prevention (CDC) said today.

Meanwhile, the World Health Organization's latest global update said flu was generally low and decreasing worldwide, but there were a few patches of activity in the tropics.

Apr 08, 2011

Apr 08, 2011

US flu level continues drop amid low global activity

(CIDRAP News) – Flu indicators in the United States and other Northern Hemisphere locations continue to plummet, with global surveillance showing only a few active areas in tropical and Southern Hemisphere locations that will soon be approaching their flu season.

Oct 13, 2010

Oct 13, 2010

H3N2 a player in early Northern Hemisphere flu season

(CIDRAP News) – More signals suggest the Southern Hemisphere's flu season is winding down, while activity is low at the start of the Northern Hemisphere's flu season, except in China, which is seeing moderate H3N2 circulation.

Pages

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»